Breast Ductal Carcinoma — Trials

Breast Ductal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

210 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 60
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 5%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (37)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05436808	Partial Chest Wall Radiation Therapy After Surgery for Lymph Node Negative Breast Cancer	withdrawn	Early Phase 1	0	Stony Brook UniversityOTHER	1	Oct 18, 2023	clinicaltrials
NCT02610920	Sentinel Lymph Node Identification in the Axilla of Women With Breast Cancer Using Ultrasound and Iron Injection	withdrawn	Early Phase 1	0	Columbia UniversityOTHER	0	Mar 26, 2019	clinicaltrials